Lipids & Metabolic

Australian researchers have uncovered yet another link between the controversial Paleolithic diet and heart disease.

Nearly two-thirds of high-risk patients prescribed PCSK9 inhibitors to lower their risk of familial hypercholesterolemia and ASCVD are rejected coverage for the drugs by their health insurers, a new study alleges.

The FDA on July 15 approved Sun Pharmaceutical Industries’ sprinkle formulation of rosuvastatin, an alternative to traditional lipid-lowerers for patients who have difficulty swallowing.

Toward the end of June, around a dozen American diabetics took an 817-mile caravan ride from Minneapolis to London, Ontario, in an effort to obtain more affordable insulin, CBS News reports. It was the second caravan in two months to make the trip.

Abbott Laboratories is planning to increase production of its lower-cost continuous glucose monitor, the FreeStyle Libre, by three to five times in the coming years, Reuters reported July 16.

A study of more than a quarter of a million heart patients in Canada has revealed statins are “significantly” underutilized to treat lipid abnormalities in individuals with and at risk for ASCVD.

Multivitamins and the bulk of nutritional supplements do little to protect heart health, in some cases increasing a person’s risk for CV events, an analysis published in the Annals of Internal Medicine has found.

A lack of formal training in nutrition could significantly limit how physicians practice, according to an editorial published in JAMA Internal Medicine this month, in some cases leading them to recommend risky treatments to patients in lieu of dietary counseling that might be just as effective.

A bariatric surgeon at the Ohio State Wexner Medical Center is advocating for a new set of clinical guidelines that would extend eligibility for weight loss surgery to thousands more patients struggling with their weight.

Fear-based “fake news” about statin therapy is driving non-adherence to the drugs in the U.S., according to an editorial published in JAMA Cardiology June 26, fostering a culture of mistrust and misinformation that could easily deter heart patients from a treatment that might be beneficial to them.

Body fat distribution could be a key predictor of heart disease risk in postmenopausal women, according to a July 1 study that found “apple”-shaped women are more prone to CVD than their “pear”-shaped counterparts.

Patients prescribed statins for CV risk reduction are more than twice as likely to develop type 2 diabetes compared to non-statin users, a study out of Ohio State University has found.